The Company is a company mainly engaged in the research, development, manufacturing, export and sale of medical hemostatic agents. The main developed products include medical hemostats and sealants with biomimetic technology. The Company was established on April 19, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 01, 2019.
Headquarters
1210, 1206, 2Cha, Ace Hitech City, 25, Seonyu-Ro 13-Gil, Yeongdeungpo-Gu
Seoul; Seoul;
Contact Details: Purchase the Inno Therapy Inc. report to view the information.
Website: http://www.innotherapy.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service